Hormone replacement therapy that combines estrogen and progestin doubles the woman 's risk of breast cancer , the British study of more than the million women has found .
The major British study has added to the evidence that hormone replacement therapy increases the risk of breast cancer , especially when women receive the combination of estrogen and progestin .